2018 MIPS Performance Period QCDR and Qualified Registry Self-Nomination Period Opens

CMS is pleased to announce that the 2018 Quality Payment Program self-nomination period for vendors interested in participating as a Qualified Registry or a Qualified Clinical Data Registry (QCDR) will begin on September 1, 2017 and will close at 5:00 PM (Eastern Time) on November 1, 2017. Please submit your completed self-nomination form prior to the close of the self-nomination period to be considered; late submissions will not be accepted.

Additional resources regarding QCDR/Qualified Registry self-nomination are available here, on cms.gov.

If you have submitted your completed 2018 self-nomination form to CMS prior to the close of the self-nomination period, and your application is ready for review, please notify us by email. Please email QCDRVendorSupport@gdit.com if you have submitted a QCDR self-nomination form for consideration, or RegistryVendorSupport@gdit.com if you have submitted a qualified registry self-nomination form. Please make sure to include your 2018 self-nomination form JIRA ticket number in the subject of your e-mail.

Should you have any questions regarding the self-nomination process for the 2018 performance period, please feel free to reach out to the Quality Payment Program Service Center:

  • Telephone (available Monday-Friday, 8:00 AM-8:00 PM Eastern Time): 1-866-288-8292 or TTY: 1-877-715-6222
  • Email: QPP@cms.hhs.gov

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Mark Isenberg, executive vice president of Zotec Partners, discusses key developments that will reshape the specialty this year. 

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.